MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Magnetic resonance imaging(MRI)"

  • 2026 International Congress

    Locus Coeruleus-Thalamic Circuit Degeneration in Parkinson’s Disease

    XL. Cui, MF. Cai, YH. Zhang (Guangzhou, Guangdong Province, China)

    Objective: This study characterizes the microstructural evolution of the locus coeruleus (LC) and its thalamic projection tract in Parkinson’s disease (PD) using free‑water imaging across…
  • 2026 International Congress

    Clinical Significance of Automatically Assessed Perivascular Space Count in Subcortical White Matter of Parkinson’s Disease

    SJ. Chung, CJ. Park, Y. Nam, YJ. Kim, PH. Lee (Seoul, Republic of Korea)

    Objective: This study aimed to examine the relationship between automatically quantified perivascular space (PVS) count located in the subcortical white matter (WM), baseline motor deficits,…
  • 2026 International Congress

    Microstructure predicts cognition after Neurostimulation in Parkinson’s disease

    L. Chen, L. Witt, A. Calvano, M. Boop, C. Nimsky, H. Dafsari, L. Timmermann, M. Belke, D. Pedrosa, P. Loehrer (Marburg, Germany)

    Objective: To identify preoperative microstructural markers that are associated with postoperative changes in cognition. Background: Subthalamic deep brain stimulation (STN-DBS) represents an established therapeutic intervention…
  • 2026 International Congress

    Plasma p-tau217 outperforms p-tau181 as a biomarker of Alzheimer’s disease co-pathology in the Lewy Body Disorders spectrum

    E. Fiorenzato, S. Cauzzo, G. Musso, R. Biundo, C. Ceolin, C. Fogliano, C. Cosma, W. Meissner, V. Misenti, S. Moz, ML. Nasi, F. Vianello, R. Manara, M. Montagnana, G. Sergi, A. Antonini (Padova, Italy)

    Objective: To evaluate the relative performance of plasma p-tau217 and p-tau181 as biomarkers of Alzheimer’s disease (AD)  co-pathology across the Lewy body disorders (LBD)  spectrum.…
  • 2026 International Congress

    DTI-Based Comparative Analysis of Microstructural Alterations in Parkinson Disease and Atypical Parkinsonism

    H. Lin, W. Dai (guangzhou, China)

    Objective: Diffusion tensor imaging (DTI) holds promising potential for investigating pathological changes in white matter (WM). In recent years, numerous studies worldwide have demonstrated that…
  • 2026 International Congress

    7 Tesla MRI with Quantitative Susceptibility Mapping: Quantitative focal measurements and qualitative grading of the substantia nigra as a biomarker for Parkinson’s Disease

    R. Unsgård, K. Stige, A. Kristoffersen, P. Goa, C. Tzoulis, E. Berntsen (Trondheim, Norway)

    Objective: To quantitatively and qualitatively evaluate susceptibility changes in the dorsal SN (dSN), using quantitative susceptibility mapping (QSM) and susceptibility-weighted imaging (SWI) at 7Tesla (7T)…
  • 2026 International Congress

    Basal Ganglia Lacunar Infarcts and Risk of Mortality and Dementia in Parkinsonism: A Population-Based Study

    L. Malfer, F. Onorati, A. Mullan, R. Savica (Rochester, USA)

    Objective: To determine the prevalence of chronic basal ganglia lacunar infarcts (BGLI) and examine their association with dementia and mortality in a population-based cohort of…
  • 2026 International Congress

    Remaining unmet needs in Essential Tremor and Parkinson’s Disease: European Neurologists’ Assessments of Pharmacologic Response and Advanced Therapy Use

    N. Kaempf, á. Sánchez Fraga, C. Tengelin, P. Crivelli, K. Gant, C. Ferrer, A. Grinspan (Frankfurt am Main, Germany)

    Objective: To investigate neurologists’ perceptions of treatment effectiveness and criteria for selecting patients for advanced therapies in essential tremor (ET) and Parkinson’s disease (PD). Background:…
  • 2026 International Congress

    Differential Cholinergic White Matter Microstructural Alterations in Multiple System Atrophy and Parkinson’s Disease

    SM. Rong, R. Yang, ZH. Li, XL. Cui, CT. He, MF. Cai, YH. Zhang (Guangzhou, Guangdong Province, China)

    Objective: To investigate the extent and pattern of microstructural alterations of cholinergic pathways in MSA and PD. Background: MSA and PD are both α-synucleinopathies with…
  • 2026 International Congress

    A Diffusion MRI Neurodegeneration Index for Lewy Body Dementia & Alzheimer’s disease

    S. Chiu, R. Chen, W. Wang, J. Desimone, A. Barmpoutis, M. Armstrong, D. Vaillancourt (Scottsdale, USA)

    Objective: To develop a diffusion MRI-based neurodegeneration index using free-water imaging and assess its ability to quantify neurodegenerative burden in Lewy body dementia (LBD) and…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 88
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley